Tupper; David Edward

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tupper; David Edward.The latest application filed is for "bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mglu2 receptor agonist".

Company Profile

0.13.7

Tupper; David Edward - Berkshire N/A GB
Tupper; David Edward - Basingstoke GB
Tupper; David Edward - Basingstoke Hampshire GB
Tupper; David Edward - Hampshire GB
Tupper; David Edward - Reading GB
Tupper; David Edward - Bracknell GB2

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist Grant 9,296,710 - Man , et al. March 29, 2	2016-03-29
Bicyclo (3.1.0) Hexane-2, 6-dicarboxylic Acid Derivatives As Mglu2 Receptor Agonist App 20140113944 - Man; Teresa Tse Ki ; et al.	2014-04-24
1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators Grant 8,168,659 - Coffey , et al. May 1, 2	2012-05-01
1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one As Cb1 Receptor Modulators App 20090275618 - Coffey; David Scott ; et al.	2009-11-05
Piperazine substituted aryl benzodiazepines Grant 7,384,934 - Aicher , et al. June 10, 2	2008-06-10
Process for preparing 2-methyl-thieno-benzodiazepine Grant RE40,033 - Chakrabarti , et al. January 22, 2	2008-01-22
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders Grant 7,214,673 - Aicher , et al. May 8, 2	2007-05-08
Substituted piperazines of azepines, oxazepines and thiazepines App 20060270656 - He; John Xiaoqiang ; et al.	2006-11-30
Piperazine substituted aryl benzodiazepines App 20060084643 - Aicher; Thomas Daniel ; et al.	2006-04-20
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders App 20050203296 - Aicher, Thomas Daniel ; et al.	2005-09-15
Pharmaceutical compounds App 20040030131 - Keenan, Martine ; et al.	2004-02-12
2-methyl-thieno-benzodiazepine formulation Grant 6,169,084 - Bunnell , et al. January 2, 2	2001-01-02
Thienobenzodiazepine compounds Grant 6,034,078 - Fairhurst , et al. March 7, 2	2000-03-07
Process for preparing 2-methyl-thieno-benzodiazepine Grant 6,008,216 - Chakrabarti , et al. December 28, 1	1999-12-28
Mental disorders Grant 5,817,656 - Beasley, Jr. , et al. October 6, 1	1998-10-06
Methods of treatment using a thieno-benzodiazepine Grant 5,817,655 - Chakrabarti , et al. October 6, 1	1998-10-06
Thieno[3,2-b]-[1,5]benzodiazepines Grant 4,115,568 - Chakrabarti , et al. September 19, 1	1978-09-19
Benzodiazepine derivatives Grant 4,115,574 - Chakrabarti , et al. September 19, 1	1978-09-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.